Fact CheckerSign in

NCT06194227Completed

Yoga Training and Retinal Vasculature With Parkinson's Disease

The Impact of Cued High-speed Interval Yoga (YogaCue) on Retinal Microvasculature, Mitochondrial Function, and Cognition in Persons With Parkinson's Disease.

Source: ClinicalTrials.gov · Last updated 3 Jan 2025

Brief summary (registry, in English)

This study will compare the impact of a novel high-speed, cued yoga program to a standard yoga program on retinal microvasculature, cognition and neuromuscular function in persons with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
21 (actual)
First submitted
11 Dec 2023
Start date
16 Jan 2024
Primary completion date
30 Dec 2024
Lead sponsor
University of Miami
NCT number
NCT06194227

What you commit to

  • Study type: Interventional
  • Participants enrolled: 21
  • From 16 Jan 2024 to the primary completion date, 30 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, or other serious concomitant medical illness;

Other illness

  • Uncontrolled cardiovascular or neuromuscular diseases that prevent participation in a training program;
  • cerebrovascular disease;
  • documented HIV infection or other immunodeficiency syndrome;
  • a history of ocular surgeries (except for cataract surgery more than 6 months ago) or other ocular diseases;

Other

  • bilateral moderate or severe cataracts;
  • refractive errors of myopia, hyperopia and/or astigmatism more than 6.0 Diopters.

Who the study is looking for

  • Parkinson's disease (H\&Y 1, 2, and 3) confirmed by pretest administration of the UPDRS,
  • 55-90 years of age,
  • Montreal Cognitive Assessment \> 17.

Age in the registry: 50 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Miami
Coordinator of this site? Confirm its status
Coral GablesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.